UBE4B and hepatocellular carcinoma: The expression of UBE4B was significantly associated with many chemokines and chemokine receptors, suggesting that UBE4B may be associated with immune regulation in HCC and that these molecules could be potential immunotherapeutic targets for UBE4B in HCC.